For the Culture By The Culture. ISSN: 3064-9331.
New York legalized cannabis and opened hundreds of stores, but regulators now warn the legal market may not produce enough weed to keep them stocked. With nearly 600 stores open and sales nearing $3 billion, the state is discovering that legalization alone does not guarantee a functioning market.
Cannabis legalization was sold as the end of the illicit market. Instead, stacked taxes, licensing limits, and local bans created price gaps that allowed underground sales to survive. From California’s cultivation tax to Illinois pricing and Michigan’s price compression, this installment of Cannabis Lie examines how policy design, not the plant, determines who wins and who stays in the shadows.
Arizona lawmakers are advancing legislation that would criminalize “excessive” marijuana odor detectable across property lines. Cannabis Lie Vol. 3 examines SB 1725 and SCR 1048, the proposed misdemeanor penalties, the legal implications of State v. Sisco, and why critics argue this is a backdoor attempt to reintroduce cannabis criminalization under the banner of nuisance law.
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.
Ohio voters approved adult use cannabis with 57 percent support in 2023. Two years later, lawmakers narrowed that framework through Senate Bill 56. A referendum campaign now seeks to overturn those revisions, requiring roughly 248,000 valid signatures statewide. This piece breaks down what changed, who changed it, and what voters are being asked to decide next.
THE CANNABIS LIE is a reporting series examining how cannabis policy turns shaky assumptions into hard penalties. In THE CANNABIS LIE: Vol. 2, The Fiction of Impairment, THC detection is often treated like proof of impairment, even though blood levels show a weak, inconsistent relationship to functional driving ability. This installment explains why per se THC limits and zero tolerance rules create false certainty, why urine metabolites only show prior exposure, and why real impairment should be demonstrated through behavior and context, not presumed from a lab result.
